1 unknown. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Unknown 1 |
Follow Bortezomib: new trials by email Literature Review of Bortezomib trials Research Report on Bortezomib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML DAG pre-excitation regimen with Bortezomib - Bortezomib, Acute Myeloid Leukemia | Phase 1 | Unknown | Zhongnan Hospital | 40 | 2020-01-01 | 2023-08-09 |
Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Leukemia (1) · Leukemia, Myeloid (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
Bortezomib (1)
China (1)
Fuling Zhou, phD (1)